The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 295, Issue 1, 2008, Pages

  Zipprich, Alexander ^a,b   Loureiro Silva, Mauricio R ^a,b   D'Silva, Irita ^b   Groszmann, Roberto J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

CCl4 cirrhotic rats; Liver perfusion; Sinusoidal

Indexed keywords

CARBON TETRACHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER PERFUSION; LIVER VEIN; MALE; NONHUMAN; OUTCOME ASSESSMENT; PORTAL VEIN; PORTAL VEIN BLOOD; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VENOUS PRESSURE; ANIMAL; BLOOD FLOW VELOCITY; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL LIVER CIRRHOSIS; HEPATIC ARTERY; LIVER; ORGAN CULTURE TECHNIQUE; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTAL VEIN BLOOD PRESSURE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; BLOOD FLOW VELOCITY; CARBON TETRACHLORIDE; HEPATIC ARTERY; HEPATIC VEINS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; ORGAN CULTURE TECHNIQUES; PORTAL PRESSURE; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR RESISTANCE; VENOUS PRESSURE;

EID: 51149090839     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00190.2007     Document Type: Article

References (33)

1. Abraldes JG, Iwakiri Y, Loureiro-Silva M, Haq O, Sessa WC, Groszmann RJ. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 290: G980-G987, 2006.
2. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 37: 902-908, 2003.
3. Ayuse T, Brienza N, O'Donnell CP, Robotham JL. Pressure-flow analysis of portal vein and hepatic artery interactions in porcine liver. Am J Physiol Heart Circ Physiol 267: H1233-H1242, 1994.
4. Ezzat WR, Lautt WW. Hepatic arterial pressure-flow autoregulation is adenosine mediated. Am J Physiol Heart Circ Physiol 252: H836-H845, 1987.
5. Fernandez-Munoz D, Caramelo C, Santos JC, Blanchart A, Hernando L, Lopez-Novoa JM. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites. Am J Physiol Gastrointest Liver Physiol 249: G316-G320, 1985.
6. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, Rodes J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 346: 1056-1059, 1995.
7. Gardemann A, Strulik H, Jungermann K. A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver. FEBS Lett 202: 255-259, 1986.
8. Groszmann RJ, Blei AT, Kniaz JL, Storer EH, Conn HO. Portal pressure reduction induced by partial mechanical obstruction of the superior mesenteric artery in the anesthetized dog. Gastroenterology 75: 187-192, 1978.
9. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M, Rofe S, Patrick M, Lerner E. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99: 1401-1407, 1990.
10. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 353: 2254-2261, 2005.
11. Groszmann RJ, Glickman M, Blei AT, Storer E, Conn HO. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology 76: 253-258, 1979.
12. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39: 280-282, 2004.
13. Hamilton RL, Berry MN, Williams MC, Severinghaus EM. A simple and inexpensive membrane "lung" for small organ perfusion. J Lipid Res 15: 182-186, 1974.
14. Hanson KM, Johnson PC. Local control of hepatic arterial and portal venous flow in the dog. Am J Physiol 211: 712-720, 1966.
15. Kleber G, Steudel N, Behrmann C, Zipprich A, Hubner G, Lotterer E, Fleig WE. Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion. Gastroenterology 116: 906-914, 1999.
16. Komeichi H, Moreau R, Cailmail S, Gaudin C, Lebrec D. Hemodynamic responses to selective blockade of beta 2- and beta 1-adrenoceptors in conscious rats with cirrhosis. J Hepatol 21: 779-786, 1994.
17. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 249: G549-G556, 1985.
18. Lautt WW, Legare DJ, d'Almeida MS. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol Heart Circ Physiol 248: H331-H338, 1985.
19. Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol 284: G567-G574, 2003.
20. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 32: 930-934, 2000.
21. Perello A, Escorsell A, Bru C, Gilabert R, Moitinho E, Garcia-Pagan JC, Bosch J. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 30: 1393-1397, 1999.
22. Richardson PD, Withrington PG. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog. J Physiol 282: 451-470, 1978.
23. Schneider AW, Kalk JF, Klein CP. Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure. J Hepatol 30: 876-881, 1999.
24. Taourel P, Blanc P, Dauzat M, Chabre M, Pradel J, Gallix B, Larrey D, Bruel JM. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology 28: 932-936, 1998.
25. Thalheimer U, Mela M, Patch D, Burroughs AK. Targeting portal pressure measurements: a critical reappraisal. Hepatology 39: 286-290, 2004.
26. Vassiliades VG, Ostrow TD, Chezmar JL, Hertzler GL, Nelson RC. Hepatic arterial resistive indices: correlation with the severity of cirrhosis. Abdom Imaging 18: 61-65, 1993.
27. Villanueva C, Balanzo J, Novella MT, Soriano G, Sainz S, Torras X, Cusso X, Guarner C, Vilardell F. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 334: 1624-1629, 1996.
28. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, Sainz S, Boadas J, Cusso X, Guarner C, Balanzo J. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 345: 647-655, 2001.
29. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol Gastrointest Liver Physiol 244: G52-G57, 1983.
30. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 87: 1120-1126, 1984.
31. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 35: 478-491, 2002.
32. Yang W, Benjamin IS, Moore K, Portmann B, Alexander B. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat. Eur J Pharmacol 461: 41-48, 2003.
33. Zipprich A, Steudel N, Behrmann C, Meiss F, Sziegoleit U, Fleig WE, Kleber G. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology 37: 385-392, 2003.